On the research front, CU Anschutz has spent $183 million from corporate and other nongovernment sponsors since 2011. The top 20, all drug companies, invested $77 million alone.

Heide Ford, Ph.D., professor and CU Medicine endowed chair in pharmacology, right, shows Sen. John Hickenlooper, center, some of the work the lab is doing during a tour for the senator at the ...

The CU-Anschutz medical campus is the home to the CU health professional schools with more than 60 centers and institutes, as well as the two hospitals that treat more than 2 million adults and ...

Now CU will seek to do a clinical trial of the two drugs. Alzheimer's affects more than 5.5 million people in the U.S., at a cost of $200 billion a year.

"Past the Pandemic" through CU Anschutz connected healthcare workers with mental health counselors for weekly meetings over Zoom. They thought it might be needed for a couple of months.

John J. Reilly, Jr., Dean of the University of Colorado School of Medicine and vice chancellor for health affairs at CU Anschutz, said the $50 million donation provides scientists the funding to ...

Starting on June 30, five University of Colorado Boulder researchers will be featured in the University of Colorado Anschutz-led Mind the Brain podcast series. The combining of expertise from both ...